Heparin Recall Import Alert: The FDA’s Role
In continuing to educate the public on issues regarding the recall of Heparin products, the FDA published informational charts regarding how the importation of Heparin is regulated.
Product Entry:
Heparin, including the Active Pharmaceutical Ingredient (API) and finished heparin, enter U.S. ports from overseas.
Import Alert:
The FDA issues an import alert on shipments from specified manufacturer(s) and product(s). If a product is imported from a manufacturer, investigators will detain the shipment.
Industry and FDA Response:
If the industry provides information and the FDA confirms that appropriate corrections have been made, the FDA will remove the manufacturer and product from the import alert.
Safe Product Alert:
The FDA continues to engage with industry to help ensure adequate supply of safe heparin reaches patients.
For additional information from the FDA, click here.
If you were harmed after being administered heparin, please complete the form below and a representative of our firm will contact you as soon as possible.
see also:
FDA: Analyzing the Contaminant
Recall Alert: FDA Process of Analyzing Heparin Contaminant--Legal InfoRecall in the News: How the FDA Analyzes the Contaminant in Heparin
March 7, 2008 Update
The FDA provides an update to questions about the Heparin recallRecall of Baxter's Heparin prompts updated information from the FDA
FDA Health Advisory
FDA Issues Advisory on Heparin Due to Health Risks--Free Lawsuit InfoDid You Suffer Adverse Reaction After Heparin Injection? Lawsuit info
